Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
153
-
Total 13F shares, excl. options
-
64M
-
Shares change
-
-3.6M
-
Total reported value, excl. options
-
$653M
-
Value change
-
-$172M
-
Put/Call ratio
-
1.21
-
Number of buys
-
77
-
Number of sells
-
-81
-
Price
-
$10.22
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2021
216 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q3 2021.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 153 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64M shares
of 101M outstanding shares and own 63.35% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (12.8M shares), VANGUARD GROUP INC (8.33M shares), BlackRock Inc. (6.64M shares), STATE STREET CORP (6.51M shares), FIRST TRUST ADVISORS LP (4.26M shares), FARALLON CAPITAL MANAGEMENT LLC (1.45M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.41M shares), TWO SIGMA INVESTMENTS, LP (1.34M shares), JPMORGAN CHASE & CO (1.27M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.25M shares).
This table shows the top 153 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.